ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 680

$897K Total Retail Price of All Prescriptions

Rank: 106 out of 680

340 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 12,550 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
NAMENDA 537 513 1 35
LISINOPRIL 507 443 2 5
POTASSIUM CHLORIDE 434 389 3 14
AMLODIPINE BESYLATE 381 332 4 1
DONEPEZIL HCL 362 342 5 27
WARFARIN SODIUM 341 316 6 20
GABAPENTIN 326 268 7 15
LEVOTHYROXINE SODIUM 314 303 8 2
FUROSEMIDE 312 300 9 6
METOPROLOL TARTRATE 294 259 10 12
EXELON 292 280 11 112
NEXIUM 277 235 12 16
PRAVASTATIN SODIUM 223 196 13 10
MELOXICAM 214 195 14 24
SERTRALINE HCL 208 176 15 28
METFORMIN HCL 203 173 16 8
ALENDRONATE SODIUM 195 195 17 32
OMEPRAZOLE 193 181 18 7
SIMVASTATIN 160 148 19 3
CLOPIDOGREL 159 131 20 26
POLYETHYLENE GLYCOL 3350 144 137 21 62
TRAMADOL HCL 144 127 21 18
LEVETIRACETAM 142 123 23 120
JANUVIA 140 140 24 60
FLUOXETINE HCL 138 138 25 74
HYDROCODONE-ACETAMINOPHEN 132 95 S3 26 4
PLAVIX 128 117 27 39
HYDRALAZINE HCL 128 102 27 71
ALLOPURINOL 121 119 29 33
CARVEDILOL 114 98 30 23
QUETIAPINE FUMARATE 112 105 31 64
METOPROLOL SUCCINATE 112 97 31 13
AZITHROMYCIN 112 108 31 42
FINASTERIDE 105 105 34 109
GLIMEPIRIDE 104 97 35 29
PANTOPRAZOLE SODIUM 104 104 35 30
LANTUS 95 75 37 49
TAMSULOSIN HCL 94 94 38 34
ESCITALOPRAM OXALATE 92 83 39 45
MIRTAZAPINE 92 92 39 78
DIGOXIN 89 88 41 58
CIPROFLOXACIN HCL 85 81 42 57
PRAMIPEXOLE DIHYDROCHLORIDE 82 79 43 204
LOSARTAN POTASSIUM 80 69 44 21
SYNTHROID 73 73 45 38
CITALOPRAM HBR 73 57 45 22
NIFEDIPINE ER 70 57 47 75
DIVALPROEX SODIUM 70 64 47 110
KLOR-CON M20 69 58 49 61
PREDNISONE 69 67 49 50
ABILIFY 67 65 51 178
AMIODARONE HCL 66 65 52 158
OLANZAPINE 64 52 53 116
ISOSORBIDE MONONITRATE ER 64 56 53 59
NOVOLIN R 64 56 53 113
HUMULIN R 64 58 53 195
PROPRANOLOL HCL 63 59 57 145
DOXAZOSIN MESYLATE 62 52 58 73
PREMARIN 62 41 R 58 105
GLIPIZIDE XL 60 60 60 142
SEROQUEL 60 48 60 123
ATORVASTATIN CALCIUM 60 60 60 11
FLUCONAZOLE 58 56 63 139
ZOLPIDEM TARTRATE 58 55 63 17
CRESTOR 56 56 65 25
DETROL LA 55 55 66 169
CYMBALTA 53 46 67 46
ADVAIR DISKUS 51 44 68 53
PROAIR HFA 50 48 69 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.